Clinical trial
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing…
NCT00077389 · University of Leicester, Other · Unknown status
Key facts
| NCT number | NCT00077389 |
|---|---|
| Title | Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma |
| Official title | Intensified Pre-Operative Chemotherapy And Radical Surgery For High Risk Hepatoblastoma |
| Lead sponsor | University of Leicester, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, cisplatin, doxorubicin hydrochloride, adjuvant therapy, conventional surgery, neoadjuvant therapy |
| Enrollment | 57 |
| Start date | Jan 1, 2004 |
| First posted | Feb 12, 2004 |
| Last update posted | Jun 24, 2014 |
| Countries | France, Ireland, Netherlands, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: